Tag: Typbar-TCV
Bharat Biotech launches iNNCOVACC, world’s first intranasal Covid-19 vaccine
The vaccine is priced at INR 325/dose for large volume procurement by state governments and union government
Bharat Biotech’s typhoid vaccine confirms high efficacy in a study by...
According to the trial’s results published in The Lancet, the TypbarTCV vaccine turned out to be 87 percent effective for infants, older children and adults, under real life conditions............